Compare IRTC & UCTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | UCTT |
|---|---|---|
| Founded | 2006 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.1B |
| IPO Year | 2016 | 2004 |
| Metric | IRTC | UCTT |
|---|---|---|
| Price | $118.89 | $118.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 3 |
| Target Price | ★ $197.92 | $97.33 |
| AVG Volume (30 Days) | 519.0K | ★ 1.3M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $747,138,000.00 | ★ $1,734,500,000.00 |
| Revenue This Year | $19.60 | $19.18 |
| Revenue Next Year | $15.94 | $17.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 26.24 | N/A |
| 52 Week Low | $100.85 | $21.28 |
| 52 Week High | $210.01 | $125.00 |
| Indicator | IRTC | UCTT |
|---|---|---|
| Relative Strength Index (RSI) | 59.07 | 61.83 |
| Support Level | $111.37 | $24.51 |
| Resistance Level | $121.88 | N/A |
| Average True Range (ATR) | 5.56 | 8.13 |
| MACD | 1.26 | 0.93 |
| Stochastic Oscillator | 85.36 | 80.94 |
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments: Products and Services. Its principal markets are the Americas, Asia Pacific, and EMEA.